Reverse Structural and Gap-junctional Remodeling After Prolonged Atrial Fibrillation in the Goat
Overview
Authors
Affiliations
Background: Prolonged atrial fibrillation (AF) results in electrical, structural, and gap-junctional remodeling. We examined the reversibility of the changes in (ultra)structure and gap junctions.
Methods And Results: Four groups of goats were used: (1) sinus rhythm (SR), (2) 4 months' AF (4 mo AF), (3) 2 months' SR after 4 mo AF (2 mo post-AF), and (4) 4 months' SR after 4 mo AF (4 mo post-AF). Atria were characterized electrophysiologically, (ultra)structure was studied by light and electron microscopy, and structural and gap-junctional protein expression was studied by immunohistochemistry or Western blotting. The atrial effective refractory period had completely returned to normal values 2 mo post-AF. Induced AF episodes still lasted for minutes at 2 and 4 mo post-AF, compared with seconds in the SR group. Structural abnormalities were still present at 2 and 4 mo post-AF, although to a lesser extent. The increased atrial myocyte diameter was back to normal at 4 mo post-AF. The number of myocytes with severe myolysis had almost normalized 4 mo post-AF, whereas myocytes with mild myolysis remained significantly increased. Extracellular matrix area fraction after 4 mo AF was similar to SR. However, the extracellular matrix fraction per myocyte had increased after 4 mo AF and remained higher post-AF. Changes in expression of structural proteins were partially restored post-AF. The reduction of connexin 40 that was observed during AF was completely reversed at 4 mo post-AF.
Conclusions: Recovery from structural remodeling after 4 mo AF is a slow process and is still incomplete 4 mo post-AF. Several months post-AF, the duration of AF episodes is still prolonged (minutes).
Ayagama T, Charles P, Bose S, Boland B, Priestman D, Aston D iScience. 2024; 27(6):109609.
PMID: 38827406 PMC: 11141153. DOI: 10.1016/j.isci.2024.109609.
Angelini E, Sieweke J, Berliner D, Biber S, Hohmann S, Oldhafer M Front Cardiovasc Med. 2024; 10:1270422.
PMID: 38164465 PMC: 10757954. DOI: 10.3389/fcvm.2023.1270422.
Huang J, Wu B, Qin P, Cheng Y, Zhang Z, Chen Y Front Cardiovasc Med. 2023; 10:1270452.
PMID: 38028487 PMC: 10663310. DOI: 10.3389/fcvm.2023.1270452.
Nakahara S, Hori Y, Fukuda R, Sato H, Aoki H, Ishikawa T Circ Rep. 2023; 5(10):371-380.
PMID: 37818284 PMC: 10561997. DOI: 10.1253/circrep.CR-23-0073.
Marcon L, Bergonti M, Spera F, Saenen J, Huybrechts W, Miljoen H Europace. 2023; 25(11).
PMID: 37787610 PMC: 10629715. DOI: 10.1093/europace/euad299.